Views & Analysis PRIME movers: taking stock of the EMA's scheme Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
News Deadline looms for EMA host city bids Europe's medicines regulator will move from London after Brexit
Views & Analysis Macron’s France: advancing towards a European vision for hea... What will Macron's government mean for healthcare in his country and Europe?
News Pharma facing uncertainty as May triggers Brexit The UK government will shortly trigger Brexit under Article 50, opening up negotiations which are expected to see the country leave the European Union by March 2019.
Views & Analysis Patient power in Europe – more work to be done What the EMA and pharma can do to promote patient involvement in decision making.
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face